PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.11%
Revenue growth 1.25-1.5x AVGO's 7.50%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
9.33%
Gross profit growth above 1.5x AVGO's 4.49%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
30.72%
Positive EBIT growth while AVGO is negative. John Neff might see a substantial edge in operational management.
30.72%
Positive operating income growth while AVGO is negative. John Neff might view this as a competitive edge in operations.
35.16%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
37.93%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
41.82%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.87%
Share reduction while AVGO is at 2.71%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.17%
Reduced diluted shares while AVGO is at 1.06%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-1.02%
Dividend reduction while AVGO stands at 2.28%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
123.95%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
138.47%
Positive FCF growth while AVGO is negative. John Neff would see a strong competitive edge in net cash generation.
116.11%
10Y revenue/share CAGR at 50-75% of AVGO's 219.16%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
36.54%
5Y revenue/share CAGR under 50% of AVGO's 184.50%. Michael Burry would suspect a significant competitive gap or product weakness.
27.37%
3Y revenue/share CAGR under 50% of AVGO's 164.70%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
45077.62%
10Y OCF/share CAGR above 1.5x AVGO's 696.78%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
53.55%
Below 50% of AVGO's 289.72%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-2.23%
Negative 3Y OCF/share CAGR while AVGO stands at 327.59%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
507.76%
Net income/share CAGR 1.25-1.5x AVGO's 340.48%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
61.81%
5Y net income/share CAGR at 75-90% of AVGO's 75.98%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
7.52%
Below 50% of AVGO's 53.03%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
244.94%
Equity/share CAGR of 244.94% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
74.59%
Below 50% of AVGO's 189.65%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
17.27%
Below 50% of AVGO's 72.91%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
19.97%
AR growth well above AVGO's 6.73%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.33%
Inventory growth well above AVGO's 3.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.69%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.47%
We have a declining book value while AVGO shows 2.63%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.44%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.88%
R&D dropping or stable vs. AVGO's 9.96%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.90%
SG&A declining or stable vs. AVGO's 32.41%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.